The Madhavan Lab offers students and postdocs valuable opportunities to engage the public and sharpen their communication skills.

Innovations from the U of A College of Medicine – Tucson, the Asthma and Airway Disease Research Center and the BIO5 Institute are targeting the deeper causes of asthma and COPD.

An FDA-approved osteoporosis treatment might nudge a mutated protein back into shape and improve heart function, according to a study by University of Arizona College of Medicine – Tucson researchers.

With antibiotic resistance on the rise, Michael D. L. Johnson, PhD, is on a mission to discover new ways to neutralize harmful microorganisms.

An international research team co-led by Sarver Heart Center Director Hesham Sadek, MD, PhD, shows that about 25% of patients with artificial hearts can regenerate heart muscle after a heart attack.

Parkinson’s disease causes difficulty in movement and balance, but its cognitive symptoms receive less attention and have no good treatments. A College of Medicine – Tucson team hopes to change that.

Rob Jackson, PhD, a postdoctoral researcher in the Department of Immunobiology, secured a pivotal National Institutes of Health grant to establish his career in virology and oral cancer.

Researchers in the Department of Psychiatry will use a $3M grant from the Department of Defense to examine a noninvasive, drug-free treatment for sleep disorders.

Department of Pediatrics researchers are working to enhance prevention and treatment options for autoimmune diseases, which can be hard to diagnose and treat.

Dr. Deepta Bhattacharya is shepherding a new era in immunology research as the inaugural executive director of the U of A Health Sciences Center for Advanced Molecular and Immunological Therapies.